Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
Encrypt Messages
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by VALEANT PHARMS NORTH
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
012093
ISORDIL
New Drug Application
Approval
017340
RETIN-A
New Drug Application
Approval
New formulation
(S) Standard review drug
018998
VASOTEC
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
019462
PEPCID
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
019568
DERMATOP
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(S) Standard review drug
019931
KLARON
New Drug Application
Approval
New formulation
(S) Standard review drug
019963
RENOVA
New Drug Application
Approval
New formulation
(S) Standard review drug
020401
TIAZAC
New Drug Application
Approval
New formulation
(S) Standard review drug
020648
DIASTAT
DIASTAT ACUDIAL
New Drug Application
Approval
New formulation
(S) Standard review drug
(V) Orphan drug
020743
NORITATE
New Drug Application
Approval
New formulation
(S) Standard review drug
020985
CARAC
New Drug Application
Approval
New formulation
(S) Standard review drug
021108
RENOVA
New Drug Application
Approval
New formulation
(S) Standard review drug
021271
IPRIVASK
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(S) Standard review drug
021894
XENAZINE
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
(V) Orphan drug
022108
APLENZIN
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(S) Standard review drug
075116
DILTIAZEM HYDROCHLORIDE
Abbreviated New Drug Application
Approval
075269
NIFEDIPINE
Abbreviated New Drug Application
Approval
075289
NIFEDIPINE
Abbreviated New Drug Application
Approval
076070
NIFEDIPINE
Abbreviated New Drug Application
Approval
086101
SECONAL SODIUM
Abbreviated New Drug Application
Approval
089772
MINITRAN
Abbreviated New Drug Application
Approval
090071
VENLAFAXINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
090715
FENOFIBRATE
Abbreviated New Drug Application
Approval
Back to Companies who have applied for FDA Drug Approval